Curevac announces voting results of general meeting

TÜbingen, germany and boston, ma / access newswire / june 24, 2025 / curevac n.v. (nasdaq:cvac), a pioneering multinational biotech company developing a new class of transformative medicines based on messenger rna (mrna), today announced the voting results of the company's annual general meeting.
CVAC Ratings Summary
CVAC Quant Ranking